. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Clin Cancer Res. 2014 Oct 3;20(23):5986–5994. doi: 10.1158/1078-0432.CCR-14-0479

Table 2.

Correlation of KIR genotype with MRD

KIR gene	% gene positive			OR (95%CI)	p value
KIR gene	All patients	Negative MRD	Positive MRD	OR (95%CI)	p value
KIR2DL1	97.9	97.7	100	0(0-Inf)	0.99
KIR2DL2	53.7	54.7	44.4	0.66(0.25–1.76)	0.41
KIR2DL3	93.2	93	94.4	1.28(0.16–10.42)	0.82
KIR2DL5A	40	36.6	72.2	4.5(1.53–13.21)	0.006
KIR2DL5B	26.8	25.6	38.9	1.85(0.68–5.07)	0.23
KIR2DS1	31.6	29.1	55.6	3.05(1.14–8.18)	0.027
KIR2DS2	48.2	48.5	44.4	0.85(0.32–2.25)	0.74
KIR2DS3	24.2	21.5	50	3.65(1.35–9.85)	0.011
KIR2DS4*001	50	50	50	1(0.38–2.64)	1
KIR2DS4*003-9	74.7	74.4	77.8	1.2(0.38–3.85)	0.76
KIR2DS5	27.4	26.2	38.9	1.8 (0.66–4.92)	0.25
KIR3DL1	97.4	97.1	100	0(0-Inf)	0.99
KIR3DS1	30	27.9	50	2.58(0.97–6.9)	0.058
KIR2DP1	97.9	97.7	100	0(0-Inf)	0.99
KIR3DL1*004	25.4	25.7	22.2	0.82(0.26–2.64)	0.75